Badreddin Edris
Director at Edgewise Therapeutics, Inc. (EWTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 23SEC | EWTXEdgewise Therapeutics, Inc. | Sell Plan | 13,690121,601 held (−10%) | $29.44 | $403K | +32.7% |
| Jan 23SEC | EWTXEdgewise Therapeutics, Inc. | Sell Plan | 17,236104,365 held (−14%) | $29.44 | $507K | +32.7% |
| Jan 23SEC | EWTXEdgewise Therapeutics, Inc. | Sell Plan | 7,60596,760 held (−7%) | $29.44 | $224K | +32.7% |
| Jan 23SEC | EWTXEdgewise Therapeutics, Inc. | Sell Plan | 10,46386,297 held (−11%) | $29.44 | $308K | +32.7% |
| Jan 23SEC | EWTXEdgewise Therapeutics, Inc. | Sell Plan | 66,47719,820 held (−77%) | $29.44 | $2.0M | +32.7% |
- Sell
Director Badreddin Edris sold $403K of EWTX at $29.44 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Badreddin Edris sold $507K of EWTX at $29.44 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Badreddin Edris sold $224K of EWTX at $29.44 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Badreddin Edris sold $308K of EWTX at $29.44 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Badreddin Edris sold $2.0M of EWTX at $29.44 — cuts the stake by 77%; pre-scheduled 10b5-1 plan sale.